ArticleFrontiers in oncology2021
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
Open access · goldAbstract readPublished Erratum
In one paragraph
Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 34 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
38 authors at 14 institutions in 1 country.
Qitong ChenDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Dengjie OuyangDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Munawar AnwarDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Ning XieDepartment of Breast Internal Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Shouman WangDepartment of Breast Surgery, Xiangya Hospital, Central South University, Changsha, China.
Peizhi FanDepartment of Breast and Thyroid Surgery, Hunan Provincial People's Hospital, Changsha, China.
Liyuan QianDepartment of Breast and Thyroid Surgery, Central South University Third Xiangya Hospital, Changsha, China.
Gannong ChenDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Enxiang ZhouDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Lei GuoDepartment of Breast Surgery, Xiangya Hospital, Central South University, Changsha, China.
Xiaowen GuDepartment of Breast and Thyroid Surgery, Hunan Provincial People's Hospital, Changsha, China.
Boni DingDepartment of Breast and Thyroid Surgery, Central South University Third Xiangya Hospital, Changsha, China.
Xiaohong YangDepartment of Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
Liping LiuDepartment of Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
Chao DengDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.
Zhi XiaoDepartment of Breast Internal Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Jing LiDepartment of Breast Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
Yunqi WangDepartment of Traditional Chinese Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
Shan ZengDepartment of Internal Medicine - Oncology, Xiangya Hospital Central South University, Changsha, China.
Jinhui HuDepartment of Breast Surgery, The First Hospital Hunan University of Chinese Medicine, Changsha, China.
Wei ZhouDepartment of Breast and Thyroid Surgery, The Affiliated ZhuZhou Hospital of Xiangya School of Medicine Central South University, Zhuzhou, China.
Bo QiuDepartment of Oncology, The Affiliated ZhuZhou Hospital of Xiangya School of Medicine Central South University, Zhuzhou, China.
Zhongming WangDepartment of Breast Surgery, The Third People's Hospital of Yongzhou, Yongzhou, China.
Jie WengDepartment of Oncology, The First People's Hospital of Yueyang, Yueyang, China.
Mingwen LiuDepartment of Breast and Thyroid Surgery, The First People's Hospital of Xiangtan City, Xiangtan, China.
Yi LiDepartment of Oncology, The Third People's Hospital of Changde, Changde, China.
Tiegang TangDepartment of Oncology, Xiangtan Central Hospital, Xiangtan, China.
Jianguo WangDepartment of General Surgery, Xiangtan Central Hospital, Xiangtan, China.
Hui ZhangDepartment of Oncology, Central Hospital of Shaoyang, Shaoyang, China.
Bin DaiDepartment of Breast and Thyroid Surgery, Central Hospital of Shaoyang, Shaoyang, China.
Wuping TangDepartment of Breast Surgery, Shaoyang Hospital of Traditional Chinese Medicine, Shaoyang, China.
Tao WuDepartment of Oncology, The First People's Hospital of Changde, Changde, China.
Maoliang XiaoDepartment of Oncology, The Third Hospital of Hunan University of Chinese Medicine, Zhuzhou, China.
Xiantao LiDepartment of Oncology, The Central Hospital of Yiyang, Yiyang, China.
Hailong LiuDepartment of Internal Medicine - Oncology, The First People's Hospital of Chenzhou, Chenzhou, China.
Lai LiDepartment of Breast and Thyroid Surgery, The People's Hospital of Xiangtan County, Xiangtan, China.
Wenjun YiDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Quchang OuyangDepartment of Breast Internal Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Central South University · CNSecond Xiangya Hospital of Central South University · CNThe Central Hospital of Shaoyang · CNHunan Provincial People's Hospital · CNThe First People's Hospital of Changde · CNXiangyang Central Hospital · CNZhuzhou Central Hospital · CNChangzhou Third People's Hospital · CNChenzhou First People's Hospital · CNFirst Affiliated Hospital of Hunan University of Traditional Chinese Medicine · CNHunan University · CNThird Xiangya Hospital · CNXiangya Hospital Central South University · CNYueyang Second People's Hospital · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
[This corrects the article DOI: 10.3389/fonc.2020.00811.].
Indexed as
breast cancerHER2metastasespyrotinibtumor mutation burden
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.